Adaptive and Bayesian Designs for Dose-Finding Webinar Registration
Finding the right dose in Phase 2 gives a potential new therapy its best chance to demonstrate efficacy during Phase 3. A well-executed dose-ranging trial therefore has the potential to alter the course of the entire clinical development program. This webinar will demonstrate how adaptive and Bayesian techniques can be implemented for optimal dose-finding.
Complete the form to access the webinar today!